Second Edition of the Cancer R&D World Conference 2026 to Advance Precision Oncology in Miami

Miami, Florida, USA - Precision Global Conferences is proud to announce the 2nd Edition of the Cancer Research and Development World Conference (CRDWC 2026), taking place from September 21-23, 2026, both in-person at Miami, Florida, USA, and virtually for global participants. This hybrid event will bring together leading international researchers, clinicians, industry experts, and healthcare professionals dedicated to pioneering breakthroughs in cancer research and development.

With the theme "Advancing Precision Oncology Through Biomarker-Driven Drug Development and Innovative Clinical Trial Design," CRDWC 2026 aims to accelerate collaborative efforts in cancer science, foster transformational research advancements, and support emerging leaders in oncology.

"We are delighted to convene global experts and innovators in Miami to exchange insights, showcase cutting-edge research, and forge partnerships that will shape the future of oncology," said the conference organizing committee. "This year's conference underscores the importance of combining precision medicine with novel therapeutic strategies to enhance patient outcomes worldwide."

CRDWC 2026 will feature a robust scientific program, including keynote presentations, oral sessions, and poster forums spanning topics such as:
• Emerging Biomarkers for Early Detection and Prognosis
• Immuno-Oncology and Cell-Based Therapies
• CAR-T Cell Therapy: Progress and Challenges
• Next-Generation Gene and Cell Therapeutics
• Cancer Prevention and Translational Research
• Innovative Clinical Trial Design and Precision Drug Development

In addition to scientific sessions, the conference offers ample opportunities for networking, collaboration, and professional growth. Attendees can participate in panel discussions, connect with leading scientists, and engage with industry partners to explore future research initiatives and clinical applications.

Registration and Abstract Submission: Researchers, clinicians, and students are encouraged to submit abstracts for oral and poster presentations and take advantage of early-bird registration pricing available until 31 March 2026.

Participants attending virtually will receive full access to live sessions, downloadable conference materials, and certificates of participation, ensuring inclusive engagement across borders.

Submit Abstract: https://www.cancerglobalconference.com/abstract-submission

Registration: https://www.cancerglobalconference.com/registration

For more information, registration details, and the full conference program, please visit: https://www.cancerglobalconference.com/

Contact:
Precision Global Conferences
Phone: +1-571-556-1014
Email: cancer@precisionglobalconferences.com
Web: https://www.cancerglobalconference.com

About Precision Global Conferences:
Precision Global Conferences is a professional event organizer dedicated to creating platforms that connect global professionals, researchers, and industry leaders. Through high-quality scientific gatherings, the organization promotes the exchange of insights and facilitates breakthroughs that drive progress in oncology and other critical research fields.

This release was published on openPR.